Hunt Biosciences has signed a collaboration agreement with Tissue Solutions that aims to promote the value of the Hunt study.
Over the last 25 years, the Hunt study has gathered blood samples from the general population of the Nord-Trondelag region in mid-Norway together with detailed phonotype and environmental data.
Hunt believes that the combination of biomedical and phenotypic information that has been collected over the past 25 years from a general population rather than a specific disease cohort can help accelerate biomarker discovery and validation.
In addition, working from a general population base gives core strengths in a whole range of key public health areas such as cancer, cardiovascular disease, diabetes, obstructive lung disease, osteoporosis and mental health.
Hunt samples are being used in academic research and through the collaboration with Tissue Solutions Hunt Biosciences aims to increase its pharma and diagnostic industry customer base.
